OPK — Opko Health Cashflow Statement
0.000.00%
Last trade - 00:00- $946.96m
- $957.97m
- $713.14m
- 36
- 68
- 61
- 55
Annual cashflow statement for Opko Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30.6 | -30.1 | -328 | -189 | -53.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 5.5 | 0.087 | 156 | 33.4 | -275 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -97.6 | -20.5 | 42.7 | 21.8 | 32.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 39.5 | 38.3 | -95.2 | -28.2 | -183 |
| Capital Expenditures | -33.7 | -32.2 | -24.6 | -16.3 | -25 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 15.4 | 68.1 | 116 | -1.92 | 377 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -18.3 | 35.9 | 91 | -18.2 | 352 |
| Financing Cash Flow Items | 0 | -0.188 | 0 | 0 | -13.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -35.1 | -10.4 | 23 | -11.3 | 184 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -13.2 | 62.5 | 18.5 | -57.3 | 350 |